Pathstone Family Office’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
$3.45M Buy
65,263
+26,296
+67% +$1.39M 0.03% 346
2023
Q2
$2.18M Sell
38,967
-2,897
-7% -$162K 0.03% 304
2023
Q1
$2.08M Sell
41,864
-88,596
-68% -$4.39M 0.03% 282
2022
Q4
$3.91M Buy
130,460
+36,990
+40% +$1.11M 0.03% 329
2022
Q3
$3.62M Buy
93,470
+71,461
+325% +$2.77M 0.03% 291
2022
Q2
$820K Sell
22,009
-3,027
-12% -$113K 0.02% 400
2022
Q1
$1.11M Buy
25,036
+10,552
+73% +$469K 0.03% 305
2021
Q4
$616K Sell
14,484
-425
-3% -$18.1K 0.02% 473
2021
Q3
$647K Buy
14,909
+1,137
+8% +$49.3K 0.02% 421
2021
Q2
$589K Buy
13,772
+1,397
+11% +$59.7K 0.02% 410
2021
Q1
$478K Buy
12,375
+1,316
+12% +$50.8K 0.02% 349
2020
Q4
$398K Buy
11,059
+968
+10% +$34.8K 0.02% 195
2020
Q3
$385K Hold
10,091
0.04% 138
2020
Q2
$354K Hold
10,091
0.04% 125
2020
Q1
$329K Sell
10,091
-80
-0.8% -$2.61K 0.05% 128
2019
Q4
$4.6M Buy
10,171
+80
+0.8% +$36.2K 0.05% 106
2019
Q3
$411K Sell
10,091
-5,000
-33% -$204K 0.05% 106
2019
Q2
$648K Buy
15,091
+5,000
+50% +$215K 0.08% 112
2019
Q1
$387K Buy
10,091
+91
+0.9% +$3.49K 0.05% 129
2018
Q4
$353K Hold
10,000
0.1% 61
2018
Q3
$385K Hold
10,000
0.12% 41
2018
Q2
$327K Hold
10,000
0.24% 36
2018
Q1
$273K Hold
10,000
0.15% 44
2017
Q4
$248K Buy
+10,000
New +$248K 0.14% 31
2017
Q2
Sell
-68
Closed -$2K 415
2017
Q1
$2K Buy
+68
New +$2K ﹤0.01% 370
2014
Q4
Sell
-125
Closed -$1K 126
2014
Q3
$1K Buy
+125
New +$1K ﹤0.01% 300
2014
Q2
Sell
-72
Closed -$1K 138
2014
Q1
$1K Buy
+72
New +$1K ﹤0.01% 167
2013
Q4
Sell
-865
Closed -$11K 211
2013
Q3
$11K Buy
+865
New +$11K 0.05% 172